BCC at ASCO 2026: Early Breast Cancer 

One of the most discussed themes at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was the continued shift toward personalized treatment for early breast cancer. Researchers presented new evidence demonstrating how genomic testing can help identify patients who may safely avoid chemotherapy, ensuring treatment decisions are guided by tumour biology rather than […]